Progressive multifocal leukoencephalopathy: Report of three cases in HIV-negative hematological patients and review of literature

Annals of Hematology

Volumn 87, Issue 5, 2008, Pages 405-412

  Pelosini, Matteo ^a   Focosi, Daniele ^a   Rita, Fazzi ^a   Galimberti, Sara ^a   Caracciolo, Francesco ^a   Benedetti, Edoardo ^a   Papineschi, Federico ^a   Petrini, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Central nervous system; HIV; Progressive multifocal leukoencephalopathy

Indexed keywords

CIDOFOVIR; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; GANCICLOVIR; IDARUBICIN; PREDNISONE; RISPERIDONE; RITUXIMAB; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BRAIN BIOPSY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CASE REPORT; DONOR LYMPHOCYTE INFUSION; DRUG DOSE ESCALATION; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; FOLLICULAR LYMPHOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; JC VIRUS; LARGE CELL LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; STEREOTACTIC BIOPSY; VIRUS DETECTION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 41549115177     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-007-0411-6     Document Type: Article

References (61)

1. Van Assche G et al (2005) Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 353(4):362-368
2. Redfearn A et al (1993) Progressive multifocal leukoencephalopathy in a child with immunodeficiency and hyperimmunoglobulinemia M. Pediatr Infect Dis J 12(5):399-401
3. Dorries KA et al (2003) Association of human polyomavirus JC with peripheral blood of immunoimpaired and healthy individuals. J Neurovirol 9(Suppl 1):81-87
4. Monaco M, Shin J, Major E (1998) JC virus infection in cells from lymphoid tissue. Dev Biol Stand 94:115-22
5. Cervetti G et al (2003) Efficacy and toxicity of liposomila included in PVABEC regime for aggressive NHL of the elderly. Leuk Lymphoma 44(3):465-469
6. Caracciolo F et al (1997) Consolidation therapy with idarubicin, cisplatin and prednisone (CIP) after P-VABEC regimen in the treatment of intermediate and high grade non-Hodgkin's lymphoma of the elderly. Leuk Lymphoma 24(3-4):355-361
7. Khouri I et al (1998) Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma. J Clin Oncol 16(12):3803-3809
8. Aversa F et al (2005) Full haplotype - mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 23(15):3447-3754
9. Focosi D et al (2006) Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: A clinical, neuroradiological and virological response after treatment with risperidone. Antiviral Res 74(2):156-158
10. Boffil-Mas S, Pina S, Girones R (2000) Documenting the epidemiology patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl Environ Microbiol 66(1):238-245
11. Arthur R et al (1988) BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis 158(3):563-569
12. Chan P et al (1994) Association between polyomaviruria and microscopic haematuria in bone marrow transplant recipients. J Infect 29(2):139-146
13. O'Shaughnessy D et al (1994) Grand Rounds-Hammersmith Hospital: clinicopathological conference dizziness and confusion after bone marrow transplantation. BMJ 309(6949):262-265
14. Owen R et al (1995) Cytomegalovirus-induced T-cell proliferation and the development of progressive multifocal leucoencephalopathy following bone marrow transplantation. Br J Haematol 89(1):196-198
15. Garcia DDV et al (2002) JC virus load in progressive multifocal leukoencephalopaty: Analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival, and the volume of neurological lesion. Clin Infect Dis 34(12):1568-1575
16. Bossolasco S et al (2005) Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 40(5):738-744
17. Pozzo D et al (2006) Conventional and diffusion weighted MRI in progressive multifocal leukoencephalopaty: New elements for identification and follow up. Radiologia Medica 111(7):971-979
18. Richardson EJ, Johnson P (1975) Atypical progressive multifocal leukoencephalopathy with plasma-cell infiltrates. Acta Neuropathol Suppl (Berl) 6:247-250
19. Cinque P, Koralnik I, Clifford D (2003) The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: Defining a consensus terminology. J Neurovirol 9(Suppl 1):88-92
20. Domingo P et al (1997) Remission of progressive multifocal leucoencephalopathy after antiretroviral therapy. Lancet 349(9064):1554-1555
21. Hall CD et al (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N Engl J Med 338(19):1345-1351
22. Malkoun I et al (2006) Role of immunity in the development of progressive multifocal leukoencephalopathy: A report of three patients with type B lymphoma and humoral immunodeficiency and six others with acquired immunodeficiency syndrome. Rev Neurol (Paris) 162(1):82-88
23. Shen X, Tan Y (2001) Detection of oligoclonal immunoglobulins in the cerebrospinal fluid by immunofixation electrophoresis. Clin Chem Lab Med 39(12):1209-1210
24. Sindic C et al (1997) Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy. J Neuroimmunol 76(1-2):100-104
25. Buckanovich R et al (1997) Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy. Ann Hematol 81(7):410-413
26. Coppo P et al (1999) Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5). Bone Marrow Trans 23(4):401-403
27. Kleinschmidt-DeMasters B, Tyler K (2005) Progressive multifocal leukoencephalopaty complicating treatment with natalizumab and interferon beta 1a for multiple sclerosis. New England J Med 354(4):369-374
28. Blick G et al (1998) Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside. Clin Infect Dis 26(1):191-192
29. Steiger M et al (1993) Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 33(4):407-411
30. Hou J, Major EO (1998) The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J Neurovirol 4(4):451-456
31. Rand K et al (1977) Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: Use of virus-containing cells in the urine to assess response to therapy. Ann Neurol 1(5):458-462
32. Conomy J et al (1974) Cytarabine treatment of progressive multifocal leukoencephalopathy. Clinical course and detection of virus-like particles after antiviral chemotherapy. JAMA 229(10):1313-1316
33. O'Riordan T et al (1990) Progressive multifocal leukoencephalopathy - remission with cytarabine. J Infect 20(1):51-54
34. Steurer M et al (2003) Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab. Transplantation 76(2):435-436
35. Aksamit A (2001) Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirol 7(4):386-390
36. De Luca A et al (1999) Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 52(4):891-892
37. Dodge R (1999) A case study: The use of cidofovir for the management of progressive multifocal leukoencephalopathy. J Assoc Nurses AIDS Care 10(4):70-74
38. Brambilla A et al (1999) Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy. J Neurol 246(8):723-725
39. Viallard J et al (2005) Successful cidofovir therapy of progressive multifocal leukoencephalopathy preceding angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 46(11):1659-1662
40. Colosimo C et al (1992) Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy. Acta Neurol Belg 92(1):24-29
41. Elphick GF et al (2004) The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306(5700):1380-1383
42. Altschuler E, Kast R (2005) The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy. Med Hypotheses 65(3):585-586
43. Astrom K, Mancall E, Richardson EJ (1958) Progressive multifocal leukoencephalopathy: A hitherto unrecognized complication of chronic lymphocytic leukaemia and Hodgkins disease. Brain 81(1):93-111
44. Gordon H, Bandmann M, Sandbank U (1971) Multiple myeloma associated with progressive multifocal leukoencephalopathy and Pneumocystis carinii pneumonia. Isr J Med Sci 7(4):581-588
45. King J et al (1981) Progressive multifocal leukoencephalopathy. Clin Exp Neurol 17:125-134
46. Ng C, Slavin M, Seymour J (2003) Progressive multifocal leukoencephalopathy complicating Waldenstrom's macroglobulinaemia. Leuk Lymphoma 44(10):1819-1821
47. Behar A (1965) Progressive multifocal leukoencephalopathy in a case of acute lymphatic leukemia. Isr J Med Sci 1(4):650-654
48. Ganguly S, Ganguly S, Biswas K (1995) Progressive multifocal leukoencephalopathy in a case of acute lymphocytic leukemia. Indian Pediatr 32(6):684-686
49. Demir E et al (2005) Childhood case of progressive multifocal leukoencephalopathy with improved clinical outcome. J Child Neurol 20(3):241-244
50. Garcia-Suarez J et al (2005) Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: Impact of novel therapies. Am J Hematol 80(4):271-281
51. Przepiorka D et al (1997) Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant 20(11):983-987
52. Re D et al (1999) Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy. Bone Marrow Transplant 23(3):295-298
53. Osorio S et al (2002) Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir. Bone Marrow Transplant 30(12):963-966
54. Goldberg SL et al (2002) Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 99(4):1486-1488
55. Kharfan-Dabaja M et al (2006) Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature. Bone Marrow Transplant 39(4):253-254
56. FDA (2006) FDA warns of safety concern regarding rituxan in new patient population. FDA News
57. Brenchley JM et al (2003) Expression of CD57 defines replicative senescence and antigen-. induced apoptotic death of CD8+ T cells. Blood 101(7):2711-2720
58. Autran B et al (1991) A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. Blood 77(10):2237-2241
59. Martin A et al (2004) Results of autologous tranplantation in lymphoma are not improved by increasing the dose ofetoposide in the BEAM regime: a single centre sequential-cohort study. Bone Marrow Transplant 44(3):675-682
60. Coiffer B (2002) Rituximab in combination with CHOP improves survival in elderly patient with aggressive non Hodgkin's lymphoma. Sem Oncol 29(2):18-22
61. Smardova L et al (2005) Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatinum(plus granulogyte colony-stimulating factor in patient with relapsed Hodgkin's disease. Leuk Lymphoma 46(7):1017-1022